HIFU Urologist Makes Strides in Prostate Cancer Treatment
11/24/2009

Dr. Michael Wolff touts HIFU procedure as the alternative to traditional prostate cancer treatment.

Online PR News – 24-November-2009 – – Charlotte, NC - A leading urologist in Burlington, North Carolina has just launched a dedicated website for patients with prostate cancer. Dr. Michael Wolff recently released HIFU.mx (http://www.hifu.mx) to the general public to better explain the benefits of utilizing high intensity focused ultrasound as an alternative to traditional prostate cancer treatment.

HIFU uses ultrasound to target areas of deep-seated tissue with pinpoint accuracy. HIFU rapidly increases the temperature which causes the heat to destruct tissue inside the focal zone.

Dr. Wolff stated, "Right now is a very exciting time as technology is becoming a major factor in determining how a patient deals with prostate cancer."

Currently the Sonablate® 500 is not approved for use in the U.S. The Sonablate® 500 remains investigational in the U.S. and is being studied for the treatment of prostate cancer in clinical trials in the U.S. HIFU and the Sonablate® 500 is in Phase III of clinical trials.

Dr. Wolff has stated his new site also includes a downloadable brochure on HIFU for patients looking for more information. For more information on HIFU and to find out if you qualify, please visit http://www.hifu.mx .

visit our website